Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel’s “Poetics of Time” Brand Positioning
SHANGHAI, Jan. 26, 2026 /PRNewswire/ — Moyom Biotechnology recently announced a strategic partnership with WPP Group, one of the world’s leading global... Read more.
SEMIFIVE and SAPIEN Semiconductors Sign MOU to Develop Next-Generation Micro-display ‘CMOS Backplane’ Technology
Accelerating commercialization by combining SEMIFIVE’s AI SoC platform with SAPIEN’s micro-LED display driver design expertise Strengthening the micro-display... Read more.
Accevo Receives Frost & Sullivan’s 2025 European Enabling Technology Leadership Recognition for Manufacturing Software in Smart Factories
The company is acknowledged for enabling digital transformation, performance-driven smart manufacturing, and scalable manufacturing software innovation across European... Read more.
Haier Shines at Australian Open 2026: Official Partner Elevates the Game with Smart Innovation and Purpose
MELBOURNE, Australia, Jan. 25, 2026 /PRNewswire/ — Haier, the world’s No.1 major home appliance brand, continues its strategic partnership with the... Read more.
Leqembi® Iqlik™ (lecanemab-irmb) supplemental Biologics License Application regarding subcutaneous starting dose granted Priority Review by the US FDA
STOCKHOLM, Jan. 25, 2026 /PRNewswire/ — BioArctic AB’s (publ) (STO: BIOA B) partner Eisai announced today that the supplemental Biologics License Application... Read more.
DigiFT Introduces First Actively Managed Tokenized Equity Fund with BNY as Investment Management Services Provider
First actively managed tokenized equity fund extending tokenization beyond single assets to professionally managed public equity strategies Tokenized on Ethereum... Read more.
Tulip Innovation Patent Claims Against Sunwoda Batteries Expand to Include KTC Action
BUDAPEST, Hungary, Jan. 26, 2026 /PRNewswire/ — On 19 January 2026, the Korea Trade Commission (KTC) instituted a case based on claims filed by Tulip Innovation... Read more.
Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes
–Topline data from the Phase II study for the treatment of diabetes are expected in the third quarter of 2026. –ASC30 demonstrated placebo-adjusted... Read more.
Hivemind Capital and CPIC Investment Management Announce Strategic Partnership to Establish $500 Million Real-World Asset Tokenization Fund
HONG KONG, Jan. 25, 2026 /PRNewswire/ — Hivemind Capital, a global investment group focused on the intersection of traditional markets and the onchain economy,... Read more.
Argo Biopharma Announces First Patient Dosed in Phase 2b Trial of siRNA Therapeutic BW-20829 in Patients with Elevated Lp(a)
SHANGHAI and BOSTON, Jan. 25, 2026 /PRNewswire/ — Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage biotechnology company committed to developing... Read more.